Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
2022 · Oncogene · 18 citations
https://doi.org/10.1038/s41388-022-02361-3
M
Masayuki Hagiwara
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
1.5K
Citations
22
h-index
36
i10-index
Masayuki Hagiwara is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Prostate Cancer Treatment and Research. The author has an h-index of 22, co-authored 105 publications.
ORCID: 0000-0002-3751-4940Papers by this author
worksEfficacy of tension-free vaginal tape compared with transobturator tape in the treatment of stress urinary incontinence in women: analysis of learning curve, perioperative changes of voiding function
2011 · BMC Urology · 13 citations
https://doi.org/10.1186/1471-2490-11-13
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
2020 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-020-14808-w
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
2025 · Cancer Immunology Immunotherapy · 3 citations
https://doi.org/10.1007/s00262-025-03945-0
309P Risk stratification of advanced urothelial carcinoma in the era of cancer immunotherapy
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.328
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat